D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
Alibaba
BABA
|
+$420M |
| 2 |
Oracle
ORCL
|
+$406M |
| 3 |
TWTR
Twitter, Inc.
TWTR
|
+$307M |
| 4 |
Apple
AAPL
|
+$306M |
| 5 |
Meta Platforms (Facebook)
META
|
+$292M |
Top Sells
| 1 |
Amazon
AMZN
|
+$673M |
| 2 |
AET
Aetna Inc
AET
|
+$378M |
| 3 |
SPDR S&P 500 ETF Trust
SPY
|
+$285M |
| 4 |
AT&T
T
|
+$255M |
| 5 |
NVIDIA
NVDA
|
+$243M |
Sector Composition
| 1 | Technology | 19.62% |
| 2 | Consumer Discretionary | 15.28% |
| 3 | Healthcare | 14.47% |
| 4 | Financials | 9.86% |
| 5 | Industrials | 8.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1276
Core Laboratories
CLB
$581M
| $3.11M | ﹤0.01% |
52,089
+40,886
| +365% | +$2.44M |
|
1277
Brinker International
EAT
$6.84B
| $3.1M | ﹤0.01% |
70,568
-76,602
| -52% | -$3.37M |
|
1278
Lennar Class A
LEN
$35.6B
| $3.1M | ﹤0.01% |
81,790
+63,935
| +358% | +$2.42M |
|
1279
Seaboard Corp
SEB
$3.78B
| $3.1M | ﹤0.01% |
876
+7
| +0.8% | +$24.8K |
|
1280
Angi Inc
ANGI
$760M
| $3.1M | ﹤0.01% |
19,270
+4,663
| +32% | +$749K |
|
1281
Ryanair
RYAAY
$31.1B
| $3.09M | ﹤0.01% |
+108,265
| New | +$3.09M |
|
1282
Sangamo Therapeutics
SGMO
$152M
| $3.09M | ﹤0.01% |
268,688
+170,876
| +175% | +$1.96M |
|
1283
Daktronics
DAKT
$1.14B
| $3.08M | ﹤0.01% |
416,386
-45,929
| -10% | -$340K |
|
|
TSRO
1284
DELISTED
TESARO, Inc.
TSRO
| $3.08M | ﹤0.01% |
41,469
+29,679
| +252% | +$2.2M |
|
|
BRSS
1285
DELISTED
Global Brass & Copper Hldgs, Inc
BRSS
| $3.07M | ﹤0.01% |
122,066
+16,123
| +15% | +$405K |
|
|
TBHC
1286
The Brand House Collective, Inc. Common Stock
TBHC
$53.2M
| $3.06M | ﹤0.01% |
321,523
-17,496
| -5% | -$167K |
|
|
ONDK
1287
DELISTED
On Deck Capital, Inc.
ONDK
| $3.05M | ﹤0.01% |
516,161
-56,997
| -10% | -$336K |
|
1288
MidCap Financial Investment
MFIC
$1.16B
| $3.04M | ﹤0.01% |
244,855
-57,867
| -19% | -$718K |
|
|
INVX
1289
Innovex International, Inc.
INVX
$1.14B
| $3.03M | ﹤0.01% |
101,014
+30,552
| +43% | +$918K |
|
|
ISEE
1290
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $3.03M | ﹤0.01% |
2,521,995
-109,122
| -4% | -$131K |
|
|
ARC
1291
DELISTED
ARC Document Solutions, Inc.
ARC
| $3.02M | ﹤0.01% |
1,474,585
-14,395
| -1% | -$29.5K |
|
1292
Eversource Energy
ES
$24.4B
| $3.02M | ﹤0.01% |
46,376
-47,190
| -50% | -$3.07M |
|
1293
Prospect Capital
PSEC
$1.29B
| $3.01M | ﹤0.01% |
477,352
| – | – |
|
|
INWK
1294
DELISTED
InnerWorkings, Inc.
INWK
| $3M | ﹤0.01% |
802,420
+393,991
| +96% | +$1.47M |
|
|
BOLD
1295
DELISTED
Audentes Therapeutics, Inc
BOLD
| $2.98M | ﹤0.01% |
139,641
+74,529
| +114% | +$1.59M |
|
|
ALTR
1296
DELISTED
Altair Engineering Inc. Class A Common Stock
ALTR
| $2.97M | ﹤0.01% |
107,845
-124,621
| -54% | -$3.44M |
|
1297
Lesaka Technologies
LSAK
$362M
| $2.96M | ﹤0.01% |
630,447
-278,955
| -31% | -$1.31M |
|
1298
ATN International
ATNI
$238M
| $2.95M | ﹤0.01% |
41,230
-4,861
| -11% | -$348K |
|
1299
Expro
XPRO
$1.43B
| $2.94M | ﹤0.01% |
93,961
+80,118
| +579% | +$2.51M |
|
|
ABMD
1300
DELISTED
Abiomed Inc
ABMD
| $2.92M | ﹤0.01% |
8,992
+2,122
| +31% | +$690K |
|